Cargando…
Response to Comment on “An Integrated Pharmacokinetic-Pharmacodynamic-Pharmacoeconomic Modeling Method to Evaluate Treatments for Adults with Schizophrenia”
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9674709/ https://www.ncbi.nlm.nih.gov/pubmed/36357767 http://dx.doi.org/10.1007/s40273-022-01213-y |
| _version_ | 1784833210024198144 |
|---|---|
| author | Piena, Marjanne A. Houwing, Natalie Kraan, Carla W. Wang, Xiaofeng Waters, Heidi Bennison, Craig |
| author_facet | Piena, Marjanne A. Houwing, Natalie Kraan, Carla W. Wang, Xiaofeng Waters, Heidi Bennison, Craig |
| author_sort | Piena, Marjanne A. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9674709 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Springer International Publishing |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-96747092022-11-20 Response to Comment on “An Integrated Pharmacokinetic-Pharmacodynamic-Pharmacoeconomic Modeling Method to Evaluate Treatments for Adults with Schizophrenia” Piena, Marjanne A. Houwing, Natalie Kraan, Carla W. Wang, Xiaofeng Waters, Heidi Bennison, Craig Pharmacoeconomics Letter to the Editor Springer International Publishing 2022-11-11 2022 /pmc/articles/PMC9674709/ /pubmed/36357767 http://dx.doi.org/10.1007/s40273-022-01213-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
| spellingShingle | Letter to the Editor Piena, Marjanne A. Houwing, Natalie Kraan, Carla W. Wang, Xiaofeng Waters, Heidi Bennison, Craig Response to Comment on “An Integrated Pharmacokinetic-Pharmacodynamic-Pharmacoeconomic Modeling Method to Evaluate Treatments for Adults with Schizophrenia” |
| title | Response to Comment on “An Integrated Pharmacokinetic-Pharmacodynamic-Pharmacoeconomic Modeling Method to Evaluate Treatments for Adults with Schizophrenia” |
| title_full | Response to Comment on “An Integrated Pharmacokinetic-Pharmacodynamic-Pharmacoeconomic Modeling Method to Evaluate Treatments for Adults with Schizophrenia” |
| title_fullStr | Response to Comment on “An Integrated Pharmacokinetic-Pharmacodynamic-Pharmacoeconomic Modeling Method to Evaluate Treatments for Adults with Schizophrenia” |
| title_full_unstemmed | Response to Comment on “An Integrated Pharmacokinetic-Pharmacodynamic-Pharmacoeconomic Modeling Method to Evaluate Treatments for Adults with Schizophrenia” |
| title_short | Response to Comment on “An Integrated Pharmacokinetic-Pharmacodynamic-Pharmacoeconomic Modeling Method to Evaluate Treatments for Adults with Schizophrenia” |
| title_sort | response to comment on “an integrated pharmacokinetic-pharmacodynamic-pharmacoeconomic modeling method to evaluate treatments for adults with schizophrenia” |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9674709/ https://www.ncbi.nlm.nih.gov/pubmed/36357767 http://dx.doi.org/10.1007/s40273-022-01213-y |
| work_keys_str_mv | AT pienamarjannea responsetocommentonanintegratedpharmacokineticpharmacodynamicpharmacoeconomicmodelingmethodtoevaluatetreatmentsforadultswithschizophrenia AT houwingnatalie responsetocommentonanintegratedpharmacokineticpharmacodynamicpharmacoeconomicmodelingmethodtoevaluatetreatmentsforadultswithschizophrenia AT kraancarlaw responsetocommentonanintegratedpharmacokineticpharmacodynamicpharmacoeconomicmodelingmethodtoevaluatetreatmentsforadultswithschizophrenia AT wangxiaofeng responsetocommentonanintegratedpharmacokineticpharmacodynamicpharmacoeconomicmodelingmethodtoevaluatetreatmentsforadultswithschizophrenia AT watersheidi responsetocommentonanintegratedpharmacokineticpharmacodynamicpharmacoeconomicmodelingmethodtoevaluatetreatmentsforadultswithschizophrenia AT bennisoncraig responsetocommentonanintegratedpharmacokineticpharmacodynamicpharmacoeconomicmodelingmethodtoevaluatetreatmentsforadultswithschizophrenia |